![]() |
COMMENTARY |
|
Refute the Lie, Don't Clone It Jim Kelly |
|
|
Americans are being misled to their suffering and death for the sake
of commercial, scientific, and political agendas. A non-stop campaign of misinformation and ungrounded hype claims America's best hope for cures lay in “therapeutic” cloning. I'm paralyzed from the chest down, with my life and dreams depending on the successful, efficient use of medical research resources. So it's not in my interests to grab at straws instead of looking at scientifically proven facts. The facts are these:
The simple truth is that therapeutic cloning is a colossal sham designed to draw crucial research resources down a fruitless path with no end in sight. Before we travel this barren path we already know it won't lead to the “promise” being primary used to justify our taking a single unnecessarily step: avoiding immune rejection. Furthermore, we know without a doubt that cloning adds massive genetic problems to those inherently involved when implanting embryonic cells in adult tissues. Since these defects include (but are by no means limited to) the misexpression of genes known to control early embryonic development and the unfolding of the genetic code, one can't help questioning the credibility of claims that cloning “might” reliably provide material to study genetic defects. However, without a doubt , “therapeutic” cloning will eventually provide genetically defective, unmatched cells needing decades of “astronomically” expensive research (according to Stem Cell Pioneer Dr. John Thomson) to explore their problems before any clinical “promise” can safely be addressed. For the sake of cures, truth, and humanity, please send the message that America's sick and disabled are much more than fodder for the advancement of commercial and research agendas under the pretext of looking for cures. Refute the therapeutic cloning lie, don't clone it. James Kelly is a 46 year-old pro-cures research advocate with spinal cord injury. He explores peer-reviewed medical journals for research avenues having strong practical potentials for leading to cures. He then encourages the researchers involved to communicate and collaborate towards bringing their work from bench to bedside. Mr. Kelly supports synergistic contact between innovative researchers, clinicians, investors, and non-profit funding. |
|
Copyright 2002 by Americans to Ban Cloning;
www.cloninginformation.org
Permission to reprint granted as long as this web site is referenced.